GB1598518A - Alpha-(acetylamino)acetic acid derivatives - Google Patents

Alpha-(acetylamino)acetic acid derivatives Download PDF

Info

Publication number
GB1598518A
GB1598518A GB24301/80A GB2430180A GB1598518A GB 1598518 A GB1598518 A GB 1598518A GB 24301/80 A GB24301/80 A GB 24301/80A GB 2430180 A GB2430180 A GB 2430180A GB 1598518 A GB1598518 A GB 1598518A
Authority
GB
United Kingdom
Prior art keywords
compound
hydrogen
phenyl
thienyl
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB24301/80A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/776,400 external-priority patent/US4113943A/en
Priority claimed from US05/789,467 external-priority patent/US4096330A/en
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of GB1598518A publication Critical patent/GB1598518A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

PATENT SPECIFICATION
( 11) 1 598 518 ( 21) Application No 2431 ( 62) Divided out of No.
( 31) Convention Applicat ( 32) Filed 10 March 1977 ( 31) Convention Applicat ( 32) Filed 21 April 1977 ( 33) United States of Am ( 44) Complete Specificati ( 51) INT CL 3 C 07 C 103 ( 52) Index at acceptance 01/80 ( 22) Filed 10 March 1978 1598517 tion No 776400 tion No 789467 in lerica (US) on published 23 Sept 1981 /30 C 07 D 307/54 333/24 ( 19) C 2 C 1470 1510 215 220 226 227 22 Y 246 247 253 254 25 Y 270 282 30 Y 313 316 31 Y 326 339 342 34 Y 366 367 368 440 586 58 Y 596 601 62 X 638 63 X 658 65 X 699 AA KK KW ( 72) Inventors UWE D TREUNER and HERMANN BREUER ( 54) a-(ACETYLAMINO)ACETIC ACID DERIVATIVES ( 71) We, E R SQUIBB & SC INC, a corporation organised and exisi under the laws of the State of Delaw United States of America, of Lawrencevi Princeton Road, Princeton, New Jer 08540, United States of America, do her.
declare the invention for which we pray t a patent may be granted to us, and method by which it is to be performed, tc particularly described in and by following statement:-
This invention provides lIl(cyanoalkyl)aminol oxoacetyll ami acetic acid derivatives More particularl provides a compound of the formula R 1-CH-COOH R 4 l 1 l NH-C-C-N-C-C=N 11 I 1 1 1 0 O R 3 R 5 wherein R 1 is hydrogen, lower all saturated or unsaturated cycloalkyl, herein defined), phenyl, phenyl-lower all substituted phenyl wherein said phenyl substituted by one or two radicals selec from halogen, lower alkyl, lower alko and hydroxy or heterocyclic group selec from 2-thienyl, 3-thienyl, 2-furyl, 3-furyl pyridyl, 3-pyridyl, and 4-pyridyl; R 3 hydrogen, lower alkyl, phenyl-lower alky cyloalkyl; and R 4 and R 5 each is hydrol or lower alkyl.
The carbon atom next to the carbo group is asymmetric (when (R, is hydrogen) so the compound can exist ir and L forms A further centre of asymme occurs when R 4 and R 5 are different.
The compounds of this invention may used as intermediates in the preparation )NS cephalosporin derivatives as described in ting our related copending patent application are, No 9580/78 Serial No 1598517.
lle The lower alkyl groups referred to rsey throughout this specification are straight or eby branched chain hydrocarbon groups containing that 1 to 7 carbon atoms, preferably I to 4 the carbons, and especially I or 2 carbons.
be Examples of the type of groups the contemplated are methyl, ethyl, propyl, isopropyl, butyl and t-butyl The lower alkoxy and lower alkylthio groups are such nol lower alkyl groups attached to an oxygen or y it sulfur, respectively, e g, methoxy, ethoxy, propoxy, methylthio, ethylthio and propylthio The phenyl-lower alkyl and diphenyl-lower alkyl groups are such lower alkyl groups attached to one or two phenyl (I) rings, preferably benzyl, phenethyl and diphenylmethyl.
The saturated and unsaturated cycloalkyl groups are the alicyclic groups having up to 7 carbons and up to 2 double bonds in the kyl, ring, i e the cycloalkyl groups cyclopropyl, (as cyclobutyl, cyclopentyl, cyclohexyl and kyl, cycloheptyl, the cycloalkenyl groups having 1 is up to 7 carbons with one double bond, ted cyclobutenyl, cyclopentenyl, cyclohexenyl xy, and cycloheptenyl and the cycloalkadienyl ted groups having up to 7 carbons with two 2 double bonds located at various positions is such as 1,4-cyclohexadienyl which is l or especially preferred.
gen The substituted phenyl groups include one or two substituents selected from xyl halogen (preferably chlorine or bromine), not lower alkyl (preferably having I to 4 a D carbons, especially methyl or ethyl), lower -try alkoxy (preferably having I to 4 carbons especially methoxy or ethoxy), and hydroxy, be e g, 2-, 3-, or 4-chlorophenyl, 2-, 3-, or 4of bromophenyl, 2-, 3-, or 4-hydroxyphenyl, 0 o L 3,5-dichlorophenyl, 2-, 3-, or 4methylphenyl, and 2-, 3 or 4-ethoxyphenyl.
The halogens are the four common halogens, of which chlorine and bromine are preferred.
The compound of the invention of formula (I) is produced from an a-amino acid ester having the formula R 1-CH-COOY ( 11) I NH 2 wherein R 1 has the same meaning as defined above and Y is a readily removable group, e.g, diphenylmethyl, nitrophenyl, dinitrophenyl, t-butyl or trimethylsilyl, which is reacted with an oxalyl halide such as oxalyl chloride to form an intermediate having the formula R 1-CH-COOY I NH C=O I C=O hal wherein hal represents halogen, preferably chlorine, in a solvent such as dioxane This intermediate is then reacted with a compound having the formula R 4 N=-C-C-NH-R 3 (IV) I R 5 e.g, in an organic solvent such as dioxane in the presence of an organic base such as dimethylaniline at a reduced temperature, e.g, about -20 C, and treatment of this intermediate with an acid, e g, trifluoroacetic acid and anisole, yields the free acid of formula (I).
Alternatively, the compound of formula (I) can be produced from starting material of formula RCH(NH 2)COOY where Y is as defined above by reacting the latter with a compound having the formula R 4 Ra I t N=-C-C N-C-C-hal 1 11 11 Rs O O Preferred compounds of this invention are the acids of formula I wherein R 1 is cyclohexadienyl, phenyl or heterocyclic selected from 2-thienyl 3-thienvl 2-furvl 3furyl, 2-pyridyl, 3-pyridyl and 4-pyridyl; and R 3, R 4 and Rs each is hydrogen or lower alkyl, especially hydrogen, and especially the D-isomers thereof.
The most preferred compounds are the acids of formula I wherein R 1 is 2-thienyl, or phenyl most especially 2-thienyl; and R 2, R 3, R 4 and Rs each is hydrogen.
Example 1 l(Cyanomethyl)aminoloxoacetyl chloride m M of cyanomethylamine hydrochloride and 25 m M of oxalyl chloride in 100 m M of absolute dioxane are heated at 60-70 while passing through a stream of nitrogen After one hour a clear solution results and there is no evidence of hydrogen chloride in the nitrogen stream The solvent is evaporated under vacuum and the residual, light brown oil is taken up in methylene chloride, filtered over charcoal and stored at-30 until it is to be used.
Example 2
D a lll(Cyanomethyl)aminoloxoacetyllaminol 2 thiophenacetic acid, diphenylmethyl ester m M of 2 D thienylglycine, diphenylmethyl ester are dissolved in 20 ml.
of methylene chloride, 10 m M of dimethylaniline are added and half the product of Example 1 is added dropwise with stirring at -20 After thirty minutes, the reaction solution is washed first with 50 ml of I N hydrochloric acid and then with 50 ml of water After drying over sodium sulfate, it is concentrated by evaporation A viscous yellow mass is obtained which solidifies upon treatment with ether This is crystallized from a little ethanol to obtain Da lll(cyanomethyl)aminol oxoacetyllaminol-2-thiopheneacetic acid, diphenylmethyl ester in the form of white crystals, yield 63 %, m p 160-161 .
Example 3
D alll(Cyanomethyl)aminoloxoacetyl J aminol 2 thiopheneacetic acid By treating the diphenylmethyl ester obtained in Example 2 with trifluoroacetic acid and anisole ( 4:1) D-a-lll(cyanomethyl)aminoloxoacetyllaminol 2 thiopheneacetic acid is obtained in 74 % yield.
The product is recrystallized from absolute ethanol to obtain white crystals, m p 1992000.
Examples 4-39
The following Examples illustrate compounds of formula I which may be prepared by the method of Example 3.
1.598 518 1,598,518 R, Ri H H H H Example R,
4 M 11 "-, c 7 8 r - i 9 s j1 1 12 C L i i 13 -31 o H CH, H H -C H 2 H CH CH, H H C Hr, H H H H C^ H CH H C^ H H CH, -CH, H -( H 2 ( H CH, H H H -CH,, H H H 14 1 i 16 31 o 17 1 (_) 1 H CH, H H H 1.598,518 R, H R, H Example R,
19 Ny H H 21 -CH, 22 23 c24 C Gir 26 _)_ 27 IF 11 , 5 "28 D_ 29 H 7) CY(C11 Y 31 c32 HO-33 14 j C-(cl 34 cl H H -C^ H H H H H -CH, H H H H H H H CH, H _( 3 -0 H H -CH, H H CH, H H H H H H H H H H H H H M -C,,H H H H H 1,598518 5 Example R,
R 3 H H CH 3 H CH 3 H CH 2 ( H H

Claims (8)

WHAT WE CLAIM IS:-
1 A compound of the formula R 1-CH-COOH R 4 I I' NH-C-C-N-C-C-N 11 11 1 1 0 O R:, R, wherein R, is hydrogen, lower al saturated or unsaturated cycloalkyl herein defined), phenyl phenyl-lower al substituted phenyl wherein said phen 3 substituted by one or two radicals selei from halogen, lower alkyl, lower alkt and hydroxy, or a heterocyclic gr selected from 2-thienyl, 3-thienyl, 2-fury furyl, 2-pyridyl, 3-pyridyl, and 4-pyridyl is hydrogen, lower alkyl, phenyl-lower a or cycloalkyl; and R 4 and R 5 each hydrogen or lower alkyl.
2 A compound as in Claim I whereir is thienyl.
3 A compound as in Claim I wherein is phenyl.
H H H H -CH 3 -CH 3
4 A compound as in Claim I wherein R, is furyl.
A compound as in Claim 1 wherein R, R 3, R 4 and R
5 each is hydrogen.
6 A compound as in Claim 1 wherein R, (I) is cyclohexadienyl, phenyl, thienyl, furyl or pyridyl; and R 3, R 4 and R 5 each is hydrogen or lower alkyl.
7 A compound as in Claim I wherein R, is phenyl or thienyl; R 3 is hydrogen or kyl, methyl; and R 4 and R 5 each is hydrogen.
(as 8 A compound as in Claim 1 wherein R, kyl, is 2-thienyl and R 3, R 4 and Rs each is yl is hydrogen.
cted 9 The D-isomer of a compound as in oxy, Claim 1.
oup 10 The D-isomer of the compound as in _ 3 Claim
8.
R, 11 A compound as in claim 1, as named ikyl or shown in any of Examples 3-39.
h is n R, n R, For the Applicants, D YOUNG & CO, Chartered Patent Agents, 9 & 10 Staple Inn, London WCIV 7RD.
Printed for Her Majesty's Stationery Office, by the Courier Press, Leamington Spa, 1981 Published by The Patent Office, 25 Southampton Buildings, London, WC 2 A l AY, from which copies may be obtained.
M 3 C O 36 J 37 A 7 L 38 Ho 39 e 1,598,518
GB24301/80A 1977-03-10 1978-03-10 Alpha-(acetylamino)acetic acid derivatives Expired GB1598518A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/776,400 US4113943A (en) 1977-03-10 1977-03-10 7β-[(2-Amino-1,2-dioxoethyl)amino]acyl cephalosporins
US05/789,467 US4096330A (en) 1977-04-21 1977-04-21 7β-[[[(2-Cyanomethyl)amino]-1,2-dioxoethyl]amino]acyl cephalosporins

Publications (1)

Publication Number Publication Date
GB1598518A true GB1598518A (en) 1981-09-23

Family

ID=27119179

Family Applications (2)

Application Number Title Priority Date Filing Date
GB24301/80A Expired GB1598518A (en) 1977-03-10 1978-03-10 Alpha-(acetylamino)acetic acid derivatives
GB9580/78A Expired GB1598517A (en) 1977-03-10 1978-03-10 7-beta-(2-amino-1,2-dioxoethyl-amino)acyl cephalosporin derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9580/78A Expired GB1598517A (en) 1977-03-10 1978-03-10 7-beta-(2-amino-1,2-dioxoethyl-amino)acyl cephalosporin derivatives

Country Status (11)

Country Link
JP (1) JPS53112896A (en)
AU (1) AU3359578A (en)
CA (1) CA1121809A (en)
DE (1) DE2808643A1 (en)
DK (1) DK105578A (en)
FR (1) FR2395273A1 (en)
GB (2) GB1598518A (en)
HU (1) HU173661B (en)
NL (1) NL7802368A (en)
NO (1) NO780835L (en)
SE (1) SE7802723L (en)

Also Published As

Publication number Publication date
DE2808643A1 (en) 1978-09-14
CA1121809A (en) 1982-04-13
JPS53112896A (en) 1978-10-02
NO780835L (en) 1978-09-12
HU173661B (en) 1979-07-28
FR2395273A1 (en) 1979-01-19
SE7802723L (en) 1978-09-11
DK105578A (en) 1978-09-11
GB1598517A (en) 1981-09-23
AU3359578A (en) 1979-08-30
NL7802368A (en) 1978-09-12

Similar Documents

Publication Publication Date Title
US6252116B1 (en) Intermediates useful in a process for synthesizing COX-2 inhibitors
JPS6324993B2 (en)
AU2015355839A1 (en) Heterocyclic derivatives and use thereof
EA002427B1 (en) Process for making dirylpyridines useful as cox-2 inhibitors
HU215051B (en) Process for producing 3-cycloalkyl-propan-amides and pharamaceutical compositions containing them as active components
Lokesh et al. Synthesis, Biological evaluation and molecular docking studies of new pyrazolines as an antitubercular and cytotoxic agents
Anderson Pyrrole Chemistry: II. 2-Pyrrolecarbonitrile, 1-Methyl-2-Pyrrolecarbonitrile, and Their Nitration Products
Katritzky et al. Convenient novel syntheses of 1, 1-bis (heteroaryl) alkanes
GB1598518A (en) Alpha-(acetylamino)acetic acid derivatives
Katritzky et al. Aminoalkylbenzotriazoles: reagents for the aminoalkylation of electron rich heterocycles
HU226999B1 (en) Process for making 2,3-diarylpyridines useful as cox-2 inhibitors, and intermediates
CA2016625A1 (en) 3,4-dehydropiperidine derivatives having psychotropic activity
US4528282A (en) Amide derivatives
DE2828578C2 (en) Thiazolidines, their manufacture and use
US4056536A (en) Pyrrolo[2,1-b][3]benzazepines
CA1056373A (en) 6-acrylamidopenicillins and 7-acrylamidocephalosporins
LV10712B (en) 2-ciano-3-hydroxypropene amides
CA2610304A1 (en) Peptide deformylase (pdf) inhibitors 4
Schmidt et al. Direct lithiation of functionally substituted acrylic acid derivatives: Lithiation of β-(2-furanyl)-and β-(2-thienyl)-acrylic acids
EP0276329A1 (en) 2,3-diaminoacrylonitrile derivatives.
Sezer et al. Diazoaldehyde Chemistry. Part 4 vilsmeier‐haack formylation of diazo compounds: A re‐investigation
Nagl et al. The BF3× OEt2-assisted conversion of nitriles into thioamides with Lawesson’s Reagent
Cooney et al. Synthesis of nitrogen heterocycles by condensation of the conjugate base of open‐chain reissert compound analogs with vinyltriphenylphosphonium bromide (schweizer's salt)
Liu et al. One-pot synthesis of novel polysubstituted 1, 1′-phenylene-bipyrrole via the double [3+ 2] cycloaddition reaction
CA1086739A (en) Mercury intermediates useful in the preparation of 2- alkoxy cephalosporins

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee